Zwischen Gesundheit und Wirtschaft: Normen und Interessenkonflikte in der behördlichen Arzneimittelregulierung im Deutschen Reich 1871–1945

The article deals with the question of why the German authorities failed to reform drug regulation between 1871 and 1945, although it was urgently required due to the fundamental pharmaceutical change. The German drug regulation was initially dominated by non-state actors. The state was faced with numerous and powerful actors who represented completely different interests and standards, especially in health and economic policy. On the one hand, the reform of pharmaceutical law was blocked because the authorities were unable to balance these multiple normativities. On the other hand, the reform was complicated by external, non-medical norms and constraints.